Cargando…
A Novel Patent Ductus Arteriosus Severity Score to Predict Clinical Outcomes in Premature Neonates
Background: Patent Ductus Arteriosus (PDA) in premature neonates has been associated with comorbidities including chronic lung disease (CLD), and death. However, the treatment of PDA remains controversial. There have been several echocardiographic variables previously used to determine the hemodynam...
Autores principales: | Umapathi, Krishna Kishore, Muller, Brieann, Sosnowski, Cyndi, Thavamani, Aravind, Murphy, Joshua, Awad, Sawsan, Bokowski, John W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033137/ https://www.ncbi.nlm.nih.gov/pubmed/35448090 http://dx.doi.org/10.3390/jcdd9040114 |
Ejemplares similares
-
Management of Patent Ductus Arteriosus in Premature Infants in 2020
por: Parkerson, Sarah, et al.
Publicado: (2021) -
Surgical treatment of patent ductus arteriosus in neonates
por: Almeida, Rui, et al.
Publicado: (2015) -
Primary Surgical Closure Should Be Considered in Premature Neonates with Large Patent Ductus Arteriosus
por: Ko, Seong-Min, et al.
Publicado: (2013) -
Relationship of Patent Ductus Arteriosus Management with Neonatal AKI
por: Guillet, Ronnie, et al.
Publicado: (2021) -
Gentamicin in Neonates with Hemodynamically Significant Patent Ductus Arteriosus
por: Sridharan, Kannan, et al.
Publicado: (2023)